139 related articles for article (PubMed ID: 7710303)
21. Two histamine H2 receptor antagonists, zolantidine and cimetidine, modulate nociception in cholestatic rats.
Hasanein P
J Psychopharmacol; 2011 Feb; 25(2):281-8. PubMed ID: 19825905
[TBL] [Abstract][Full Text] [Related]
22. Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation.
Seifert R; Höer A; Schwaner I; Buschauer A
Mol Pharmacol; 1992 Aug; 42(2):235-41. PubMed ID: 1381044
[TBL] [Abstract][Full Text] [Related]
23. Positive inotropic activity of the novel histamine H2-receptor agonist, amthamine, on the human heart in vitro.
Poli E; Pozzoli C; Spaggiari I; Bertaccini G
Gen Pharmacol; 1994 Dec; 25(8):1649-54. PubMed ID: 7721041
[TBL] [Abstract][Full Text] [Related]
24. Positive inotropic effect of histamine on guinea pig left atrium: H1-receptor-induced stimulation of phosphoinositide turnover.
Sakuma I; Gross SS; Levi R
J Pharmacol Exp Ther; 1988 Nov; 247(2):466-72. PubMed ID: 2846821
[TBL] [Abstract][Full Text] [Related]
25. Zolantidine-induced attenuation of morphine antinociception in rhesus monkeys.
Hough LB; Nalwalk JW; Battles AH
Brain Res; 1990 Aug; 526(1):153-5. PubMed ID: 1981852
[TBL] [Abstract][Full Text] [Related]
26. Effects of betahistine, a histamine H1 agonist and H3 antagonist, in a light/dark test in mice.
Imaizumi M; Miyazaki S; Onodera K
Methods Find Exp Clin Pharmacol; 1996; 18(1):19-24. PubMed ID: 8721252
[TBL] [Abstract][Full Text] [Related]
27. Actions of the brain-penetrating H2-antagonist zolantidine on histamine dynamics and metabolism in rat brain.
Hough LB; Jackowski S; Eberle N; Gogas KR; Camarota NA; Cue D
Biochem Pharmacol; 1988 Dec; 37(24):4707-11. PubMed ID: 3202904
[TBL] [Abstract][Full Text] [Related]
28. H2-receptor-mediated stress-induced analgesia is dependent on neither pituitary nor adrenal activation.
Gogas KR; Hough LB
Pharmacol Biochem Behav; 1988 Jul; 30(3):791-4. PubMed ID: 2905473
[TBL] [Abstract][Full Text] [Related]
29. Interaction of ranitidine and famotidine with guinea pig-isolated parietal cells.
Sewing KF; Hannemann H
Pharmacology; 1986; 33(5):274-8. PubMed ID: 2432626
[TBL] [Abstract][Full Text] [Related]
30. Influence of histamine receptors on basal left ventricular contractile tone in humans: assessment using the H2 receptor antagonist famotidine and the beta-adrenoceptor antagonist esmolol as pharmacologic probes.
Borow KM; Ehler D; Berlin R; Neumann A
J Am Coll Cardiol; 1992 May; 19(6):1229-36. PubMed ID: 1348751
[TBL] [Abstract][Full Text] [Related]
31. Anti-ovulatory activity of H2 receptor blockers in albino rabbits--a preliminary study.
Agrawal SS; Jose MA
Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):142-6. PubMed ID: 21281096
[TBL] [Abstract][Full Text] [Related]
32. Adenosine antagonizes the histamine-induced stimulation of human atrial myocardium: protection by H1-receptor blockade.
Genovese A; Levi R
Prog Clin Biol Res; 1987; 230():345-60. PubMed ID: 2884675
[TBL] [Abstract][Full Text] [Related]
33. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic.
Hough LB; Nalwalk JW; Lu Q; Shan Z; Svokos K; Wentland MP; Montero MJ
Eur J Pharmacol; 2005 Oct; 522(1-3):38-46. PubMed ID: 16216240
[TBL] [Abstract][Full Text] [Related]
34. Further study on the effects of histamine H2 receptor agonist and antagonists on restraint-induced antinociception in mice.
Wong JC
Methods Find Exp Clin Pharmacol; 1999; 21(6):403-7. PubMed ID: 10445232
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of 2-deoxy-D-glucose antinociception, but not hyperphagia by zolantidine, a histamine (H2) receptor antagonist.
Koch JE; Hough LB; Bodnar RJ
Pharmacol Biochem Behav; 1992 Feb; 41(2):371-6. PubMed ID: 1349437
[TBL] [Abstract][Full Text] [Related]
36. Cognitive involvement by negative modulation of histamine H2 receptors in passive avoidance task in mice.
Onodera K; Miyazaki S; Imaizumi M
Methods Find Exp Clin Pharmacol; 1998 May; 20(4):307-10. PubMed ID: 9658380
[TBL] [Abstract][Full Text] [Related]
37. A role for histamine and H2-receptors in opioid antinociception.
Gogas KR; Hough LB; Eberle NB; Lyon RA; Glick SD; Ward SJ; Young RC; Parsons ME
J Pharmacol Exp Ther; 1989 Aug; 250(2):476-84. PubMed ID: 2547933
[TBL] [Abstract][Full Text] [Related]
38. Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
Pendleton RG; Torchiana ML; Chung C; Cook P; Wiese S; Clineschmidt BV
Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):4-16. PubMed ID: 6141772
[TBL] [Abstract][Full Text] [Related]
39. [Studies on histamine H2-receptor antagonistic property of FRG-8813, a novel anti-ulcer drug].
Inaba N; Shibata M; Onodera S; Tanaka M; Suzuki T; Yamaura T; Ohnishi H
Nihon Yakurigaku Zasshi; 1995 Apr; 105(4):231-41. PubMed ID: 7774860
[TBL] [Abstract][Full Text] [Related]
40. Effects of histamine and related compounds on regional cerebral blood flow in rats.
Suzuki G; Chen Z; Sugimoto Y; Fujii Y; Kamei C
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):613-7. PubMed ID: 10669907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
